Arkolith/Insider Trading/SNDX/Form 4

Morrison Briggs

DirectorSyndax Pharmaceuticals Inc (SNDX) · full profile →Form 4 · filed Aug 10, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$966K
Net Open-Market Flow
-$966K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 9, 2023Sell(S)53K$18.27$966K18K
Aug 9, 2023Option exercise(M)53K$8.77$464K71K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 9, 2023Option exercise(M)53K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-006262) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML